Vaccine developer Inovio Pharmaceuticals (AMEX:INO) said on Wednesday that CEO Joseph Kim will present an overview of the company at three investor conferences.
Inovio said Kim will present at the Stifel Nicolaus Healthcare conference held at the Four Season Hotel at 9:10 a.m. EDT on Sept. 7, in Boston.
The second presentation will take place in New York, at the Rodman & Renshaw 13th Annual Healthcare conference, held at the Waldorf Astoria, on Sept. 12 at 10:25 a.m EDT.
Meanwhile, the company’s third presentation is set to be held at the JMP Securities 6th Annual Healthcare Conference, at the St. Regis in New York on Sept. 27, at 11 a.m. EDT
A live and archived webcast of the presentations will be accessible on the company’s website athttp://www.inovio.com.
Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases.
Its SynCon vaccines are designed to provide broad cross-strain protection against known, as well as newly emergent unmatched strains of pathogens such as influenza.
The Blue Bell, Pennsylvania-based company’s shares traded at $0.74 late Wednesday afternoon on the AMEX Exchange.